Royer Leandro, Ríos Eduardo
Department of Molecular Biophysics and Physiology, Rush University School of Medicine, Chicago, IL 60612, USA.
J Physiol. 2009 Jul 1;587(Pt 13):3101-11. doi: 10.1113/jphysiol.2009.171934. Epub 2009 Apr 29.
Since its discovery in 1971, calsequestrin has been recognized as the main Ca(2+) binding protein inside the sarcoplasmic reticulum (SR), the organelle that stores and upon demand mobilizes Ca(2+) for contractile activation of muscle. This article reviews the potential roles of calsequestrin in excitation-contraction coupling of skeletal muscle. It first considers the quantitative demands for a structure that binds Ca(2+) inside the SR in view of the amounts of the ion that must be mobilized to elicit muscle contraction. It briefly discusses existing evidence, largely gathered in cardiac muscle, of two roles for calsequestrin: as Ca(2+) reservoir and as modulator of the activity of Ca(2+) release channels, and then considers the results of an incipient body of work that manipulates the cellular endowment of calsequestrin. The observations include evidence that both the Ca(2+) buffering capacity of calsequestrin in solution and that of the SR in intact cells decay as the free Ca(2+) concentration is lowered. Together with puzzling observations of increase of Ca(2+) inside the SR, in cells or vesicular fractions, upon activation of Ca(2+) release, this is interpreted as evidence that the Ca(2+) buffering in the SR is non-linear, and is optimized for support of Ca(2+) release at the physiological levels of SR Ca(2+) concentration. Such non-linearity of buffering is qualitatively explained by a speculation that puts together ideas first proposed by others. The speculation pictures calsequestrin polymers as 'wires' that both bind Ca(2+) and efficiently deliver it near the release channels. In spite of the kinetic changes, the functional studies reveal that cells devoid of calsequestrin are still capable of releasing large amounts of Ca(2+) into the myoplasm, consistent with the long term viability and apparent good health of mice engineered for calsequestrin ablation. The experiments therefore suggest that other molecules are capable of providing sites for reversible binding of large amounts of Ca(2+) inside the sarcoplasmic reticulum.
自1971年被发现以来,肌集钙蛋白一直被认为是肌浆网(SR)内主要的Ca(2+)结合蛋白,肌浆网是储存并根据需要动员Ca(2+)以激活肌肉收缩的细胞器。本文综述了肌集钙蛋白在骨骼肌兴奋-收缩偶联中的潜在作用。首先,鉴于引发肌肉收缩所需动员的离子量,考虑对SR内结合Ca(2+)的结构的定量需求。简要讨论了主要在心肌中收集到的关于肌集钙蛋白两种作用的现有证据:作为Ca(2+)储存库和作为Ca(2+)释放通道活性的调节剂,然后考虑了一项初步工作的结果,该工作操纵了肌集钙蛋白的细胞含量。这些观察结果包括证据表明,随着游离Ca(2+)浓度降低,溶液中肌集钙蛋白的Ca(2+)缓冲能力以及完整细胞中SR的Ca(2+)缓冲能力均下降。再加上在Ca(2+)释放激活后,细胞或囊泡组分中SR内Ca(2+)增加的令人困惑的观察结果,这被解释为SR中Ca(2+)缓冲是非线性的证据,并且在SR Ca(2+)浓度的生理水平下针对支持Ca(2+)释放进行了优化。这种缓冲的非线性通过一种推测进行了定性解释,该推测整合了其他人首先提出的观点。该推测将肌集钙蛋白聚合物描绘为既结合Ca(2+)又能将其有效地递送至释放通道附近的“导线”。尽管有动力学变化,但功能研究表明,缺乏肌集钙蛋白的细胞仍能够向肌浆中释放大量Ca(2+),这与为肌集钙蛋白缺失而设计的小鼠的长期生存能力和明显良好健康状况一致。因此,这些实验表明,其他分子能够在肌浆网内提供大量Ca(2+)可逆结合的位点。